Development of Novel Therapies, Models, and Biomarkers for Osteoclast-Related Diseases

Pharmacology, Toxicology and Pharmaceutical Science

• Collagen Type 2 100%
• Inflammation 33%
• Mouse Model 33%
• Receptor 33%
• Cell Culture 33%
• Nuclear Factor 33%
• Adenosine Triphosphatase 33%
• Osteoclast Differentiation Factor 33%
• Hydrochloric Acid 33%

Immunology and Microbiology

• Cartilage 94%
• Macrophage Colony-Stimulating Factor 35%
• Inflammation 11%
• Macrophage 11%
• Inflammatory Arthritis 11%
• Osteolysis 11%
• Hematopoietic Stem Cell Transplantation 11%
• Monocyte 11%